Actively Recruiting
PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection
Led by Children's Hospital of Fudan University · Updated on 2026-03-16
30
Participants Needed
1
Research Sites
221 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Ceftazidime avitbatan sodium is a broad-spectrum antibiotic with an antimicrobial spectrum covering resistant gram-negative bacteria. Its use in pediatric intensive care for severe infections is not unusual. Pathophysiological changes in severe sepsis can lead to significant changes in pharmacokinetics and pharmacodynamics during continuous renal replacement therapy.This research aims to study change of pharmacokinetic and pharmacodynamic in severe infection children with extracorporeal life support, thus improve the treatment of severe sepsis and sepsis shock.
CONDITIONS
Official Title
PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children who are admitted in the pediatric intensive care unit receiving ceftazidime avitbatan sodium
You will not qualify if you...
- No Informed Consent signed
- Participate in other clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's hosptial of fudan university
Shanghai, Shanghai Municipality, China, 201102
Actively Recruiting
Research Team
Y
Yixue Wang, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here